Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raül Rigo-Bonnin

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Clinical Biochemistry|October 7, 2018
Traceability of immunosuppressant's mass concentration results obtained using different commercial calibratorsRaül Rigo-Bonnin, Francesca Canalias
Clinical Chemistry and Laboratory Medicine|January 18, 2005
On the origin of BAK requirements for imprecisionXavier Fuentes-Arderiu, Raül Rigo-Bonnin
Clinical Chemistry and Laboratory Medicine|March 12, 2014
Measurement uncertainty and clinical interpretation of measurement resultsXavier Fuentes-Arderiu, Raül Rigo-Bonnin
Clinical Chemistry and Laboratory Medicine|April 25, 2018
Measurement uncertainty and metrological traceability of whole blood cyclosporin A mass concentration results obtained by UHPLC-MS/MSRaül Rigo-Bonnin, Pedro Alía, Francesca Canalias
Clinical Biochemistry|May 12, 2018
Different top-down approaches to estimate measurement uncertainty of whole blood tacrolimus mass concentration valuesRaül Rigo-Bonnin, Aurora Blanco-Font, Francesca Canalias
Clinical Chemistry and Laboratory Medicine|May 26, 2012
Disadvantages of using biological variation data for reference change valuesXavier Fuentes-Arderiu, Ariadna Padró-Miquel, Raül Rigo-Bonnin
Scandinavian Journal of Clinical and Laboratory Investigation|January 21, 2012
Significance of a change between two consecutive measured valuesAriadna Padró-Miquel, Raül Rigo-Bonnin, Xavier Fuentes-Arderiu
Therapeutic Drug Monitoring|January 27, 2017
Therapeutic Drug Monitoring of Everolimus: Comparability of Concentrations Determined by 2 Immunoassays and a Liquid Chromatography Tandem Mass Spectrometry MethodMaria Shipkova, Sonja Rapp, Raül Rigo-Bonnin, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 24, 2007
Pooling imprecision for interpretative purposesRaül Rigo-Bonnin, Ariadna Padró-Miquel, José Valero-Politi, et al.
Therapeutic Drug Monitoring|December 7, 2017
Multicenter Evaluation of a New Electrochemiluminescence Immunoassay for Everolimus Concentrations in Whole BloodAlain G Verstraete, Raül Rigo-Bonnin, Pierre Wallemacq, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Clinical Biochemistry|October 7, 2018
Traceability of immunosuppressant's mass concentration results obtained using different commercial calibratorsRaül Rigo-Bonnin, Francesca Canalias
Clinical Chemistry and Laboratory Medicine|January 18, 2005
On the origin of BAK requirements for imprecisionXavier Fuentes-Arderiu, Raül Rigo-Bonnin
Clinical Chemistry and Laboratory Medicine|March 12, 2014
Measurement uncertainty and clinical interpretation of measurement resultsXavier Fuentes-Arderiu, Raül Rigo-Bonnin
Clinical Chemistry and Laboratory Medicine|April 25, 2018
Measurement uncertainty and metrological traceability of whole blood cyclosporin A mass concentration results obtained by UHPLC-MS/MSRaül Rigo-Bonnin, Pedro Alía, Francesca Canalias
Clinical Biochemistry|May 12, 2018
Different top-down approaches to estimate measurement uncertainty of whole blood tacrolimus mass concentration valuesRaül Rigo-Bonnin, Aurora Blanco-Font, Francesca Canalias
Clinical Chemistry and Laboratory Medicine|May 26, 2012
Disadvantages of using biological variation data for reference change valuesXavier Fuentes-Arderiu, Ariadna Padró-Miquel, Raül Rigo-Bonnin
Scandinavian Journal of Clinical and Laboratory Investigation|January 21, 2012
Significance of a change between two consecutive measured valuesAriadna Padró-Miquel, Raül Rigo-Bonnin, Xavier Fuentes-Arderiu
Therapeutic Drug Monitoring|January 27, 2017
Therapeutic Drug Monitoring of Everolimus: Comparability of Concentrations Determined by 2 Immunoassays and a Liquid Chromatography Tandem Mass Spectrometry MethodMaria Shipkova, Sonja Rapp, Raül Rigo-Bonnin, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 24, 2007
Pooling imprecision for interpretative purposesRaül Rigo-Bonnin, Ariadna Padró-Miquel, José Valero-Politi, et al.
Therapeutic Drug Monitoring|December 7, 2017
Multicenter Evaluation of a New Electrochemiluminescence Immunoassay for Everolimus Concentrations in Whole BloodAlain G Verstraete, Raül Rigo-Bonnin, Pierre Wallemacq, et al.
Pageof 3